- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative Hepatic and Intestinal Efflux Transport of Statins
Authors
Keywords
-
Journal
DRUG METABOLISM AND DISPOSITION
Volume 49, Issue 9, Pages 750-759
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Online
2021-06-24
DOI
10.1124/dmd.121.000430
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Febuxostat, But Not Allopurinol, Markedly Raises the Plasma Concentrations of the Breast Cancer Resistance Protein Substrate Rosuvastatin
- (2020) Minna Lehtisalo et al. CTS-Clinical and Translational Science
- Binding Site Interactions of Modulators of Breast Cancer Resistance Protein, Multidrug Resistance-Associated Protein 2, and P-Glycoprotein Activity
- (2020) Feng Deng et al. MOLECULAR PHARMACEUTICS
- Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis and network meta-analysis of randomized trials with 94,283 participants
- (2019) Henock G Yebyo et al. AMERICAN HEART JOURNAL
- Quantitative contribution of six major transporters to the hepatic uptake of drugs: 'SLC-phenotyping' using primary human hepatocytes
- (2019) Yi-an Bi et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Protein Abundance of Clinically Relevant Drug Transporters in The Human Kidneys
- (2019) Stefan Oswald et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effects of SLCO1B1 and GATM gene variants on rosuvastatin-induced myopathy are unrelated to high plasma exposure of rosuvastatin and its metabolites
- (2018) Xue Bai et al. ACTA PHARMACOLOGICA SINICA
- Protein Abundance of Clinically Relevant Drug Transporters in the Human Liver and Intestine: A Comparative Analysis in Paired Tissue Specimens
- (2018) Marek Drozdzik et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015
- (2017) Gregory A. Roth et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers
- (2016) Rafael B. R. León-Cachón et al. BMC CANCER
- Why Does the Intestine Lack Basolateral Efflux Transporters for Cationic Compounds? A Provocative Hypothesis
- (2016) William R. Proctor et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Emerging Transporters of Clinical Importance: An Update From the International Transporter Consortium
- (2013) K M Hillgren et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- LC–MS/MS-based quantification of clinically relevant intestinal uptake and efflux transporter proteins
- (2013) C. Gröer et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Understanding the Critical Disposition Pathways of Statins to Assess Drug–Drug Interaction Risk During Drug Development: It's Not Just About OATP1B1
- (2012) R Elsby et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Hepatocyte Hopping of OATP1B Substrates Contributes to Efficient Hepatic Detoxification
- (2012) D Iusuf et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Impact of ABCC2, ABCG2 and SLCO1B1 Polymorphisms on the Pharmacokinetics of Pitavastatin in Humans
- (2012) Eun Sil Oh et al. Drug Metabolism and Pharmacokinetics
- Pitavastatin: An overview
- (2011) Yasushi Saito ATHEROSCLEROSIS SUPPLEMENTS
- Function of MRP1/ABCC1 is not dependent on cholesterol or cholesterol-stabilized lipid rafts
- (2011) Peter Meszaros et al. BIOCHEMICAL JOURNAL
- Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
- (2011) M. Niemi et al. PHARMACOLOGICAL REVIEWS
- Validation of membrane vesicle-based breast cancer resistance protein and multidrug resistance protein 2 assays to assess drug transport and the potential for drug–drug interaction to support regulatory submissions
- (2011) Robert Elsby et al. XENOBIOTICA
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Basolateral Efflux Mediated by Multidrug Resistance-Associated Protein 3 (Mrp3/Abcc3) Facilitates Intestinal Absorption of Folates in Mouse
- (2010) Yoshiaki Kitamura et al. PHARMACEUTICAL RESEARCH
- No significant effect ofABCB1haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin
- (2009) Jenni E. Keskitalo et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
- (2009) J E Keskitalo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Functional Characterization of Multidrug Resistance-Associated Protein 3 (Mrp3/Abcc3) in the Basolateral Efflux of Glucuronide Conjugates in the Mouse Small Intestine
- (2009) Y. Kitamura et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Different effects of theABCG2c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin
- (2009) Jenni E Keskitalo et al. PHARMACOGENOMICS
- ABCB1 Haplotypes Differentially Affect the Pharmacokinetics of the Acid and Lactone Forms of Simvastatin and Atorvastatin
- (2008) JE Keskitalo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Intestinal Breast Cancer Resistance Protein (BCRP)/Bcrp1 and Multidrug Resistance Protein 3 (MRP3)/Mrp3 Are Involved in the Pharmacokinetics of Resveratrol
- (2008) K. van de Wetering et al. MOLECULAR PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now